China’s new drug approvals take market scale beyond US$13 billion as innovation picks up
China has approved 113 innovative drugs since its 14th five-year plan began in 2021, according to data shared at a forum in Shanghai on the development of the domestic medicine industry. The number of approvals already marked an increase of nearly three times over the previous five-year plan, and had reached a market scale of…
